A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

5/15/2026, 10:56 AM

Summary of Bill SRES 732

This is Senate Resolution 732 of the 119th Congress, introduced on May 14, 2026. The resolution expresses the Senate's support for recognizing over 25 years of evidence and numerous studies demonstrating the safety and efficacy of mifepristone. It calls for equitable, transparent laws and policies regarding access to time-sensitive medication abortion, based on peer-reviewed scientific evidence.

Current Status of Bill SRES 732

Bill SRES 732 is currently in the status of Bill Introduced since May 14, 2026. Bill SRES 732 was introduced during Congress 119 and was introduced to the Senate on May 14, 2026. Bill SRES 732's most recent activity was Referred to the Committee on Health, Education, Labor, and Pensions. as of May 14, 2026

Bipartisan Support of Bill SRES 732

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill SRES 732

Primary Policy Focus

Alternate Title(s) of Bill SRES 732

A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.